HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesAssetsScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

Regunera

FDA

Regulatory intelligence
FDAapproval84% confidence

Preventing Accidental Apoquel Chewable Overdoses

Source: FDA

Why This Matters

Why this matters: illustrates how regulators handled a comparable approval decision relevant to veterinary pharmaceutical companies; the same agency is already in play for this signal, so precedent weight is higher.

Regulatory Analysis

The FDA has received an increasing number of reports of pets accidentally overdosing on Apoquel Chewable (oclacitinib chewable tablets), a flavored chewable medicine approved only for dogs.

Supporting Context

Therapeutic area
Veterinary Medicine · Parasitology
Sub-indication
General

Related signal: FDA Grants EUA for Ivermectin Liquid to Prevent New World Screwworm in Horses

Source

View source document

Related Signal

Open signal — FDA Grants EUA for Ivermectin Liquid to Prevent New World Screwworm in Horses
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.